Diagnostic Services
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 636.43 | 506.50 | 470.36 | - | - |
Total Expenses | 566.42 | 426.30 | 383.85 | - | - |
Profit Before Tax | 70.01 | 80.20 | 86.51 | - | - |
Profit After Tax | 56.84 | 62.11 | 68.39 | - | - |
Operating Profit after Depreciation | 86.50 | 87.90 | 105 | - | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 647.15 | 470.68 | 385.69 | - | - |
Total Non Current Assets | 750.73 | 686.98 | 542.01 | - | - |
Total Current Assets | 421.19 | 222.92 | 334.15 | - | - |
TOTAL ASSETS | 1,171.91 | 909.89 | 876.15 | - | - |
Total Shareholder's Fund | 809.80 | 738.74 | 684.41 | - | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2017 | FY 2016 |
---|---|---|---|---|---|
Net Cash from Operating Activities | 24.35 | 76.30 | 128.42 | 64.02 | -22.55 |
Net Cash used in Investing Activities | -128.88 | -108.89 | -240.64 | -53.98 | -46.53 |
Net Cash used in Financing Activities | 84.19 | -33.15 | 175.99 | -40.57 | 105.41 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 606.82 | 483.49 | 469.82 | 661.48 | 271.38 |
Total Expenses | 534.87 | 401.30 | 380.22 | 366.02 | 429.71 |
Profit Before Tax | 71.94 | 82.19 | 89.60 | 295.45 | -158.33 |
Profit After Tax | 58.56 | 63.51 | 70.70 | 184.93 | -111.95 |
Operating Profit after Depreciation | 88.41 | 89.87 | 108.09 | 321.39 | -133.67 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 647.15 | 470.68 | 385.69 | 308.51 | 275.10 |
Total Non Current Assets | 749.16 | 685.64 | 541.29 | 356.39 | 416.35 |
Total Current Assets | 422.41 | 223.75 | 335.77 | 252.89 | 213.63 |
TOTAL ASSETS | 1,171.57 | 909.38 | 877.05 | 609.28 | 629.98 |
Total Shareholder's Fund | 815.24 | 742.50 | 686.75 | 231.87 | -196.98 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | 24.39 | 75.48 | 128.71 | 118.66 | 37.81 |
Net Cash used in Investing Activities | -128.88 | -108.54 | -241.10 | -67.37 | -76.65 |
Net Cash used in Financing Activities | 84.21 | -33.13 | 176.04 | 20.03 | 5.78 |
Particulars (in ₹ Cr.) | 2024-09 | 2024-06 | 2024-03 | 2023-12 | 2023-09 |
---|---|---|---|---|---|
Total Revenue | 186.34 | 170.23 | 166.28 | 158.32 | 155.45 |
Total Expenses | 136.94 | 127.56 | 122.58 | 120.93 | 123.67 |
Profit Before Tax | 25.40 | 23.20 | 22.60 | 16.09 | 13.42 |
Profit After Tax | 19.60 | 17.92 | 18.73 | 12.97 | 10.50 |
Operating Profit after Depreciation | 53.99 | 49.99 | 48.04 | 41.47 | 35.94 |
Particulars (in ₹ Cr.) | 2024-09 | 2024-06 | 2024-03 | 2023-12 | 2023-09 |
---|---|---|---|---|---|
Total Revenue | 178.72 | 163.16 | 159.33 | 151.55 | 146.85 |
Total Expenses | 126.24 | 120.18 | 116.05 | 116.72 | 115.58 |
Profit Before Tax | 28.49 | 23.53 | 22.18 | 16.87 | 14.18 |
Profit After Tax | 21.97 | 18.18 | 18.42 | 13.59 | 11.31 |
Operating Profit after Depreciation | 57.08 | 50.30 | 47.62 | 38.91 | 35.43 |
₹2.5/Share
Company | Price | Market Cap (in ₹ Cr) |
---|---|---|
Krsnaa Diagnostics Ltd | ₹838.25 | ₹2,706.69 |
Max Healthcare Institute Ltd | ₹1,078.10 | ₹1,04,805.56 |
Apollo Hospitals Enterprise Ltd | ₹6,918.65 | ₹99,479.57 |
Fortis Healthcare Ltd | ₹639.80 | ₹48,302.22 |
Syngene International Ltd | ₹832.10 | ₹33,495.10 |
Global Health Ltd | ₹1,055.75 | ₹28,356.11 |
28 Oct 2024, 02:41 pm
19 Oct 2024, 10:21 am
26 Sep 2024, 06:43 pm
26 Sep 2024, 06:40 pm
26 Sep 2024, 03:17 pm